title: Committee opinion no. 502: primary ovarian insufficiency in the adolescent.
abstract: Primary ovarian insufficiency has been diagnosed in adolescents as young as age 14 years. It is estimated that approximately 1% of the female population in the United States is affected by primary ovarian insufficiency. Evaluation for all potential causes of amenorrhea, or a change from regular to irregular menses for 3 or more consecutive months, including pregnancy, polycystic ovary syndrome, hypogonadal amenorrhea, thyroid abnormalities, hyperprolactinemia, or primary ovarian insufficiency is important for young females. Understanding the unique concerns and needs associated with the diagnosis and treatment of ovarian insufficiency in adolescents is essential for the provision of quality health care for this population.
mesh_terms: D000293:Adolescent; D001851:Bone Diseases, Metabolic / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology; D002869:Chromosome Aberrations; D015897:Comorbidity; D064420:Drug-Related Side Effects and Adverse Reactions; D004700:Endocrine System Diseases / Q000453:epidemiology; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D005600:Fragile X Syndrome / Q000150:complications; D006801:Humans; D016649:Primary Ovarian Insufficiency / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000523:psychology; D011372:Progestins / Q000008:administration & dosage; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D055815:Young Adult
chemical_list: D004967:Estrogens; D011372:Progestins